U.S., Aug. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07118098) titled 'INNODIA Family & Friends Early-Stage T1D Detection Protocol' on Aug. 05.
Brief Summary: The purpose of INNODIA DETECT is to identify people who are at increased risk of developing T1D. We are doing this by testing for markers in the blood (autoantibodies) that tell us an individuals risk of getting T1D in the future.
What is Type 1 Diabetes (T1D)? T1D is a serious disease where the blood glucose (sugar) level is too high because the body cannot make a hormone called insulin.
This happens when the body's immune system attacks the cells in the pancreas that make insulin (called beta cells), meaning that insulin production stops.
Th...